Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record2038 flagged findings
Reported transactions (Form 4)54since Jan 3, 2023 · and 5 other holdings
Corporate events (8-K)24since Mar 1, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-12share offering or dilution eventrecentOpen filing ↗“…stock at the exercise price that is described in the applicable prospectus supplement. Warrants will be exercisable during the…”
+1 more passage from the same document
- “…of (i) our common stock, (ii) our preferred stock, which we may issue in one or more series, (iii) warrants, (iv) senior or…”
- 2026-05-12capital return (buybacks/dividends)recentOpen filing ↗“…the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not…”
+1 more passage from the same document
- “…the fixed maturity of or the time for payment of interest on any debt security; • reduce the principal, premium or interest payable…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
1 reverse split in 5 years (1:5.69 on Dec 31, 2022) · 1:5.69 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 203)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 14, 268-K ↗Current report · Other events new
- Oct 5, 268-K ↗Current report · Other events
- Sep 15, 268-K ↗Current report · Other events
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Results
- Aug 7, 268-K/A ↗Current report · A senior executive left or was appointed · amendment
- Jul 27, 26SCHEDULE 13G/A ↗Passive stake · Orin Hirschman · 3.3% · event on Jun 30, 26 · amendment
- Jun 25, 268-K ↗Current report · Shareholder vote results
- May 13, 26DEFA14A ↗Shareholder meeting and votes
- May 13, 26DEF 14A ↗Shareholder meeting and votes
- May 12, 268-K ↗Current report · Entered a material agreement
- May 12, 26424B5 ↗Securities offering
- May 12, 2610-Q ↗Quarterly report
- May 12, 268-K ↗Current report · Results · Other events
- Apr 9, 26Form 4 ↗Insider transaction
- Apr 9, 26Form 3 ↗Insider transaction
- Apr 2, 268-K ↗Current report · A senior executive left or was appointed
- Mar 20, 26424B3 ↗Securities offering
- Mar 19, 26CORRESP ↗Correspondence with the SEC
- Mar 19, 26UPLOAD ↗Correspondence with the SEC
- Mar 16, 26S-3 ↗Securities offering
- Mar 16, 2610-K ↗Annual report
- Mar 16, 268-K ↗Current report · Results
- Mar 12, 26SCHEDULE 13G ↗Passive stake · Dr. Reddy's Laboratories, Inc. · 9.7% · event on Jan 30, 26
- Jan 30, 268-K ↗Current report · Entered a material agreement
203 filings on record, the oldest from Sep 15, 22.
Listing the 25 most recent filings of the 203 on record.
1311
- Aug 7, 26A senior executive left or was appointed8-K/A 5.02 ↗
- May 12, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Apr 2, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 30, 26Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Oct 27, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Nov 5, 24A senior executive left or was appointed8-K 5.02 ↗
- Oct 31, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 22, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Aug 19, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 5, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- May 20, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- May 8, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
7 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- DME Advisors GP, L.L.C.9.9%Dec 31, 24SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Dr. Reddy's Laboratories, Inc.9.7%Jan 30, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- The Vanguard Group4.3%Dec 31, 25SCHEDULE 13G/A ↗
- Orin Hirschman3.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Nov 14, 24Buy$13KDAVID S SNYDERChief Financial Officer↗
- Nov 13, 24Buy$37KArun SwaminathanChief Executive Officer↗
- Nov 11, 24Buy$37KArun SwaminathanChief Executive Officer↗
- Nov 11, 24Buy$20KFred GrossmanChief Medical Officer↗
- Aug 22, 23Buy$4KAnn Lee↗
- Jan 3, 23Buyamount n/aDOV A GOLDSTEIN MD↗
- Jan 3, 23Buyamount n/aAnabella Villalobos↗
- Jan 3, 23Buyamount n/aHideki Garren↗
- Jan 3, 23Buyamount n/aDAVID S SNYDERChief Financial Officer↗
- Jan 3, 23Buyamount n/aAdrian HepnerChief Medical Officer↗
- Jan 3, 23Buyamount n/aAnn Lee↗
- Jan 3, 23Buyamount n/aHoward BermanChief Executive Officer↗
Stock compensation, tax and giftsshow the 2 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 14 transactions and goes back to Jan 3, 23.
Its sector and its market
Coya Therapeutics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Coya Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Coya Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 203 documents on file, from Sep 15, 2022 to Oct 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.